
BLTE vs ERAS
$BLTE vs $ERAS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BLTE vs ERAS: the quick read
- ·BLTE is the larger company by market cap ($6.14B vs $5.41B).
- ·ERAS has been more active on our scanner (147 vs 23 alerts in 30 days).
- ·BLTE has the smaller float (39.0M vs 303.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·ERAS trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·ERAS draws far more of our scanner's attention, 147 unusual-volume alerts in 30 days against 23, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 14% of each other on market cap, which makes the rest of this table the interesting part.
- ·ERAS is the one in play today, trading about 2.1x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BLTE and ERAS on TheDesperateTrader.
- Is BLTE or ERAS the better stock?
- "Better" depends on your goal, and these two are not alike. BLTE is the larger company by market cap ($6.14B vs $5.41B). ERAS has been more active on our scanner (147 vs 23 alerts in 30 days). BLTE has the smaller float (39.0M vs 303.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BLTE and ERAS?
- The differences that matter: they are not in the same business - BLTE is pharmaceutical preparations and ERAS is pharmaceutical preparations; they are similar in size ($6.14B vs $5.41B); they trade at very different share prices ($153.00 vs $15.43); BLTE sits at 62% of its 52-week range against 60% for ERAS; our scanner flagged BLTE 23 times in the last 30 days against 147 for ERAS. Everything above is measured from the latest completed session and SEC filings.
- Which of BLTE and ERAS is more active right now?
- Right now BLTE is at about 0.8x its normal volume and ERAS is at about 2.1x, so ERAS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BLTE or ERAS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore BLTE and ERAS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.